BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20638688)

  • 1. Donor pretreatment with DHMEQ improves islet transplantation.
    Takahashi T; Matsumoto S; Matsushita M; Kamachi H; Tsuruga Y; Kasai H; Watanabe M; Ozaki M; Furukawa H; Umezawa K; Todo S
    J Surg Res; 2010 Sep; 163(1):e23-34. PubMed ID: 20638688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S
    Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo.
    Watanabe M; Dewan MZ; Okamura T; Sasaki M; Itoh K; Higashihara M; Mizoguchi H; Honda M; Sata T; Watanabe T; Yamamoto N; Umezawa K; Horie R
    Int J Cancer; 2005 Mar; 114(1):32-8. PubMed ID: 15523684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent manner.
    Tatetsu H; Okuno Y; Nakamura M; Matsuno F; Sonoki T; Taniguchi I; Uneda S; Umezawa K; Mitsuya H; Hata H
    Mol Cancer Ther; 2005 Jul; 4(7):1114-20. PubMed ID: 16020669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats.
    Contreras JL; Eckstein C; Smyth CA; Sellers MT; Vilatoba M; Bilbao G; Rahemtulla FG; Young CJ; Thompson JA; Chaudry IH; Eckhoff DE
    Diabetes; 2003 Dec; 52(12):2935-42. PubMed ID: 14633854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-kappaB inhibitor.
    Matsumoto G; Muta M; Umezawa K; Suzuki T; Misumi K; Tsuruta K; Okamoto A; Toi M
    Int J Oncol; 2005 Nov; 27(5):1247-55. PubMed ID: 16211219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality.
    Contreras JL; Smyth CA; Bilbao G; Young CJ; Thompson JA; Eckhoff DE
    Transplantation; 2002 Nov; 74(9):1252-9. PubMed ID: 12451262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines.
    Ruan HY; Masuda M; Ito A; Umezawa K; Nakashima T; Yasumatsu R; Kuratomi Y; Yamamoto T; Weinstein IB; Komune S
    Head Neck; 2006 Feb; 28(2):158-65. PubMed ID: 16355386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of donor age on mouse islet characteristics and transplantation.
    Juang JH; Hsu BR; Kuo CH; Yaot NK
    Cell Transplant; 2001; 10(3):277-84. PubMed ID: 11437073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-3 inhibitor prevents apoptosis of human islets immediately after isolation and improves islet graft function.
    Nakano M; Matsumoto I; Sawada T; Ansite J; Oberbroeckling J; Zhang HJ; Kirchhof N; Shearer J; Sutherland DE; Hering BJ
    Pancreas; 2004 Aug; 29(2):104-9. PubMed ID: 15257101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
    Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
    Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells.
    Horiguchi Y; Kuroda K; Nakashima J; Murai M; Umezawa K
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):793-8. PubMed ID: 14686701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-induced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice.
    Ferrer-Garcia JC; Merino-Torres JF; Pérez Bermejo G; Herrera-Vela C; Ponce-Marco JL; Piñon-Selles F
    Cell Transplant; 2003; 12(8):849-57. PubMed ID: 14763504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of inflammatory cytokine secretion from mouse microglia cells by DHMEQ, an NF-kappaB inhibitor.
    Takatsuna H; Morita S; Nagatsu T; Sawada M; Umezawa K
    Biomed Pharmacother; 2005 Jul; 59(6):318-22. PubMed ID: 15932789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular design and biological activities of NF-kappaB inhibitors.
    Umezawa K; Chaicharoenpong C
    Mol Cells; 2002 Oct; 14(2):163-7. PubMed ID: 12442886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cell secretory molecules improve the functional survival of human islets.
    Hong TW; Caxaria S; Daniels Gatward LF; Hussain S; Zhao M; King AJF; Rackham CL; Jones PM
    Diabet Med; 2023 Dec; 40(12):e15227. PubMed ID: 37728506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene.
    Contreras JL; Bilbao G; Smyth CA; Jiang XL; Eckhoff DE; Jenkins SM; Thomas FT; Curiel DT; Thomas JM
    Transplantation; 2001 Apr; 71(8):1015-23. PubMed ID: 11374395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death.
    Contreras JL; Eckstein C; Smyth CA; Bilbao G; Vilatoba M; Ringland SE; Young C; Thompson JA; Fernández JA; Griffin JH; Eckhoff DE
    Diabetes; 2004 Nov; 53(11):2804-14. PubMed ID: 15504960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.